マウスモデル市場：タイプ、技術、治療領域、用途別-2024-2030年の世界予測

マウスモデル市場規模は、2023年に14億9,000万米ドルと推定され、2024年には16億1,000万米ドルに達し、CAGR 8.34%で2030年には26億1,000万米ドルに達すると予測されています。

マウスモデルは、科学者や研究者が遺伝子工学、創薬、治療試験に関連する生物医学研究や研究に使用する実験用マウス（Mus musculus）です。ヒトとマウスは遺伝的、生物学的、行動学的に類似しているため、これらのモデルはヒトの疾病プロセスを模倣する上で極めて重要です。マウスモデルにより、科学界は病気のメカニズムを理解し、薬剤の有効性を評価し、ヒトで試験する前に潜在的な治療法を探ることができます。個別化医療に対する需要の増加、様々な遺伝性疾患の有病率の増加、がん、心血管疾患、神経疾患を含む生物医学研究の急増が、マウスモデルの使用率を高めています。また、医薬品に対する規制当局の承認の増加により、広範な前臨床試験が必要となり、マウスモデルの需要をさらに促進しています。大きな成長にもかかわらず、マウスモデル市場は、動物実験に関連する倫理的懸念、遺伝子操作されたマウスモデルの作成と維持のための高コスト、マウスでヒトの病気を再現することの複雑さなど、いくつかの課題に直面しています。しかし、CRISPR/Cas9遺伝子編集技術の絶え間ない発展は、より正確で多様な疾患モデルを作成するための新たな道を提示しています。加えて、世界中の官民両部門による生物医学研究開発への投資が増加していることも、市場を大きく後押ししています。

タイプ遺伝子治療の成果を評価するための遺伝子改変マウスの重要性の高まり

条件付きマウスや外科的に改変されたマウスは、マウスのゲノムには本来存在しないヒトの状態を表すモデルを作るために、外科的介入によって特別に改変されます。このような改変には、特定の臓器の除去、腫瘍のイントロダクション、あるいは傷害モデルの作成などが含まれます。この手法により、疾患メカニズムの研究、手術技術の開発、治療薬の評価を、再現を目指すヒトの生理学的状態を忠実に模倣した制御された環境下で行うことができます。遺伝子操作マウス（GEM）は、遺伝物質を操作することによって作製されます。遺伝子ノックアウト、遺伝子ノックイン、遺伝子導入などの技術を用いて、マウスゲノム内の特定の遺伝子を導入、除去、改変します。このカテゴリーのマウスモデルは、遺伝子の機能、疾患の遺伝的基盤、遺伝子改変の潜在的影響を研究するために重要です。ハイブリッド／コンジェニックマウスは、特定の遺伝的背景を得るために2つ以上の系統の遺伝物質を組み合わせるための制御された繁殖戦略によって生産されます。ハイブリッドマウスは、2つの異なる近交系を交配することにより、ヘテロ接合性と幅広い遺伝的多様性を提供し、一般的な健康と繁殖成績に有益です。一方、コンジェニックマウスは、ハイブリッドマウスを元の近交系マウスのひとつに何世代にもわたって戻し交配することによって作出され、特定の遺伝形質や遺伝子座を分離することができます。近交系マウスは、少なくとも20世代におよぶ兄弟姉妹あるいは親子間の交配から生まれたもので、遺伝的に均一な系統が得られます。これらのマウスは遺伝的背景が一貫しているため、実験研究におけるばらつきを最小限に抑えることができ、研究において非常に貴重です。近交系マウスは遺伝学、免疫学、疾患モデルの研究に広く用いられ、遺伝子操作モデルの開発や薬理学的・毒物学的研究のプラットフォームとしても利用されています。近交系マウスは遺伝的に多様な個体群であり、意図的にヘテロ接合体を維持しています。この遺伝的多様性はヒト集団内の遺伝的多様性を反映しており、毒性学、薬理学、安全性評価研究に特に有用です。

応用マウスモデルの採用が増加し、臨床試験前の治療効果および安全性プロファイルの調査が可能に

創薬・薬剤開発におけるマウスモデルの応用は、製薬業界にとって不可欠です。ヒトとマウスは生理学的、遺伝学的に類似しているため、新規医薬化合物の有効性と安全性を評価する上で非常に貴重な存在です。マウスモデルを利用することにより、研究者は潜在的な治療薬の薬物動態学的および薬力学的特性を解明することができ、さらなる開発のための有望な薬剤候補を同定することができます。さらに、これらのモデルは、ヒト臨床試験に入る前に、新薬の作用機序、用量反応関係、潜在的毒性を理解するのに役立ち、後の開発段階での失敗のリスクを最小限に抑えることができます。マウスモデルは、個別化医療の進歩において極めて重要です。遺伝子改変マウスや患者由来異種移植片（PDX）を用いることで、研究者はヒトの遺伝的状態や疾患を高い精度で模倣することができます。これにより、遺伝的構成に基づく治療薬に対する個々の反応を研究することが可能となり、より正確で効果的な治療戦略につながります。個別化マウスモデルは、疾患診断のためのバイオマーカーの同定、治療成績の予測、標的治療の評価に役立っています。医薬品開発や個別化医療において重要な役割を果たすだけでなく、マウスモデルは様々な生物医学研究用途に広く使用されています。遺伝学の研究、疾病メカニズムの解明、免疫学的反応のテスト、環境因子が健康に与える影響の評価などです。マウスモデルは、がん、心血管疾患、糖尿病、神経疾患などの複雑な疾患に関する知識を深める上で、非常に重要な役割を担っています。その多用途性と適応性は、再生医療研究や老化研究にも適しており、生物医学的知識の拡大と新たな治療法の探求に大きく貢献しています。

地域別の洞察

研究機関や製薬会社による継続的な調査活動により、南北南北アメリカでキーワ-ド市場は大きく成長しています。さらに、連邦政府による医薬品開発やワクチン開発への助成金や投資が、同地域におけるマウスモデルの市場規模を拡大しています。しかし、欧州諸国における遺伝性疾患や神経合併症の増加により、加齢関連疾患を理解するためのマウスモデルの利用が増加しています。さらに、新興の臨床研究機関や有利な政府の取り組みがEMEA地域の市場開拓を後押ししています。個別化治療に対するニーズの高まり、老人性疾患の急増、免疫疾患の症例の増加、感染症の有病率の増加が、南北アメリカおよび欧州地域でのマウスモデルの採用を後押ししています。一方、アジア太平洋地域は、臨床活動のための研究活動や政府のイニシアチブの増加により、予測期間中にマウスモデル市場が大きく成長する見込みです。アジア太平洋地域の人口増加と慢性疾患の蔓延は、広範な調査の必要性を強調し、マウスモデルの採用を促進しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはマウスモデル市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、マウスモデル市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.マウスモデル市場の市場規模および予測は？

2.マウスモデル市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.マウスモデル市場の技術動向と規制枠組みは？

4.マウスモデル市場における主要ベンダーの市場シェアは？

5.マウスモデル市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 薬物試験や免疫疾患の調査におけるマウスモデルの利用拡大
    • 投資と助成金の増加と医薬品研究開発活動の急増
  • 抑制要因
    • マウスモデルの開発に伴う高コスト
  • 機会
    • マウスモデリングにおけるAIとMLの新たな実装
    • マウスモデリングにおけるCRISPR-Cas9技術の登場
  • 課題
    • 調査における動物の倫理的使用を考慮した厳格な規制と法律
• 市場セグメンテーション分析
  • タイプ：遺伝子治療の結果を評価するための遺伝子操作マウスの重要性の高まり
  • 応用：臨床試験前に治療効果と安全性プロファイルを調査するためのマウスモデルの採用増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 マウスモデル市場：タイプ別

• 条件付け/外科手術により改変されたマウス
• 遺伝子組み換えマウス
• ハイブリッド/コンジェニックマウス
• 近交系マウス
• 近交系マウス

第7章 マウスモデル市場：技術別

• クリスパー/CAS9
• 胚性幹細胞注入
• マイクロインジェクション
• 核移植

第8章 マウスモデル市場治療領域別

• 心血管疾患
• 免疫学
• 代謝性疾患
• 神経学
• 腫瘍学

第9章 マウスモデル市場：用途別

• 医薬品の発見と開発
• 個別化医療
• 調査アプリケーション

第10章 南北アメリカのマウスモデル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のマウスモデル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマウスモデル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • バイオサイトジェンがRenMiceシリーズを正式に発売
  • NeoMabのご紹介：GemPharmatechの革新的な抗体遺伝子ヒト化マウスモデル
  • 吠えるネズミ：中国の科学者が遺伝子を完全に再プログラムした初の哺乳類を誕生
  • UCLAの研究者らがハンチントン病の初のヒトゲノムトランスジェニックマウスモデルを開発
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. MICE MODEL MARKET RESEARCH PROCESS
• FIGURE 2. MICE MODEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. MICE MODEL MARKET DYNAMICS
• FIGURE 7. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICE MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICE MODEL MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL MICE MODEL MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL MICE MODEL MARKET SIZE, BY CONDITIONED/SURGICALLY MODIFIED MICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL MICE MODEL MARKET SIZE, BY CONDITIONED/SURGICALLY MODIFIED MICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL MICE MODEL MARKET SIZE, BY HYBRID/CONGENIC MICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL MICE MODEL MARKET SIZE, BY HYBRID/CONGENIC MICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL MICE MODEL MARKET SIZE, BY INBRED MICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL MICE MODEL MARKET SIZE, BY INBRED MICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL MICE MODEL MARKET SIZE, BY OUTBRED MICE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL MICE MODEL MARKET SIZE, BY OUTBRED MICE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL MICE MODEL MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL MICE MODEL MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL MICE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL MICE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL MICE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL MICE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL MICE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL MICE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL MICE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL MICE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL MICE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL MICE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL MICE MODEL MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL MICE MODEL MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL MICE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL MICE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL MICE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL MICE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL MICE MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL MICE MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL MICE MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL MICE MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL MICE MODEL MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL MICE MODEL MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. BRAZIL MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 68. BRAZIL MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. CANADA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 76. CANADA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 77. CANADA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 78. CANADA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 79. CANADA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 80. CANADA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 81. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. MEXICO MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. MEXICO MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. MEXICO MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 86. MEXICO MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 87. MEXICO MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 88. MEXICO MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. UNITED STATES MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 92. UNITED STATES MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 93. UNITED STATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 94. UNITED STATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 95. UNITED STATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 96. UNITED STATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 97. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 104. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 106. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 110. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 111. AUSTRALIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 112. AUSTRALIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 113. AUSTRALIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 114. AUSTRALIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 115. AUSTRALIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 116. AUSTRALIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 117. AUSTRALIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. AUSTRALIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. CHINA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. CHINA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. CHINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 122. CHINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 123. CHINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 124. CHINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 125. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 126. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 127. INDIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. INDIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. INDIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 130. INDIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 131. INDIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 132. INDIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 133. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. INDONESIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 136. INDONESIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 137. INDONESIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 138. INDONESIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 139. INDONESIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 140. INDONESIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 141. INDONESIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. INDONESIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. JAPAN MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 144. JAPAN MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 145. JAPAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 146. JAPAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 147. JAPAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 148. JAPAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 149. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 150. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 151. MALAYSIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 152. MALAYSIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 153. MALAYSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 154. MALAYSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 155. MALAYSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 156. MALAYSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 157. MALAYSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. MALAYSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. PHILIPPINES MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 160. PHILIPPINES MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 161. PHILIPPINES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 162. PHILIPPINES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 163. PHILIPPINES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 164. PHILIPPINES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 165. PHILIPPINES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. PHILIPPINES MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. SINGAPORE MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 168. SINGAPORE MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 169. SINGAPORE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 170. SINGAPORE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 171. SINGAPORE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 172. SINGAPORE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 173. SINGAPORE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. SINGAPORE MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. SOUTH KOREA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 178. SOUTH KOREA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 180. SOUTH KOREA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. SOUTH KOREA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. TAIWAN MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 184. TAIWAN MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 185. TAIWAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 186. TAIWAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 187. TAIWAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 188. TAIWAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 189. TAIWAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. TAIWAN MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. THAILAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 192. THAILAND MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 193. THAILAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 194. THAILAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 195. THAILAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 196. THAILAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 197. THAILAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. THAILAND MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. VIETNAM MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. VIETNAM MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. VIETNAM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 202. VIETNAM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 203. VIETNAM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 204. VIETNAM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 205. VIETNAM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 206. VIETNAM MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 217. DENMARK MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. DENMARK MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. DENMARK MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 220. DENMARK MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 221. DENMARK MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 222. DENMARK MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 223. DENMARK MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. DENMARK MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. EGYPT MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 226. EGYPT MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 227. EGYPT MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 228. EGYPT MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 229. EGYPT MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 230. EGYPT MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 231. EGYPT MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. EGYPT MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. FINLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 234. FINLAND MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 235. FINLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 236. FINLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 237. FINLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 238. FINLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 239. FINLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. FINLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. FRANCE MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. FRANCE MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. FRANCE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 244. FRANCE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 245. FRANCE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 246. FRANCE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 247. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 248. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 249. GERMANY MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 250. GERMANY MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 251. GERMANY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 252. GERMANY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 253. GERMANY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 254. GERMANY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 255. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 256. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 257. ISRAEL MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 258. ISRAEL MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 259. ISRAEL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 260. ISRAEL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 261. ISRAEL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 262. ISRAEL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 263. ISRAEL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. ISRAEL MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. ITALY MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. ITALY MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. ITALY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 268. ITALY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 269. ITALY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 270. ITALY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 271. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. NETHERLANDS MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 274. NETHERLANDS MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 275. NETHERLANDS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 276. NETHERLANDS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 277. NETHERLANDS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 278. NETHERLANDS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 279. NETHERLANDS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. NETHERLANDS MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. NIGERIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 282. NIGERIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 283. NIGERIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 284. NIGERIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 285. NIGERIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 286. NIGERIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 287. NIGERIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 288. NIGERIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 289. NORWAY MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 290. NORWAY MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 291. NORWAY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 292. NORWAY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 293. NORWAY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 294. NORWAY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 295. NORWAY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 296. NORWAY MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 297. POLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 298. POLAND MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 299. POLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 300. POLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 301. POLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 302. POLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 303. POLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 304. POLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 305. QATAR MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 306. QATAR MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 307. QATAR MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 308. QATAR MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 309. QATAR MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 310. QATAR MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 311. QATAR MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 312. QATAR MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 313. RUSSIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 314. RUSSIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 315. RUSSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 316. RUSSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 317. RUSSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 318. RUSSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 319. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 320. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 321. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 322. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 323. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 324. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 325. SAUDI ARABIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 326. SAUDI ARABIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 327. SAUDI ARABIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 328. SAUDI ARABIA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 329. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 330. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 331. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 332. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 333. SOUTH AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 334. SOUTH AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 335. SOUTH AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 336. SOUTH AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 337. SPAIN MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 338. SPAIN MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 339. SPAIN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 340. SPAIN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 341. SPAIN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 342. SPAIN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 343. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 344. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 345. SWEDEN MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 346. SWEDEN MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 347. SWEDEN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 348. SWEDEN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 349. SWEDEN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 350. SWEDEN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 351. SWEDEN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 352. SWEDEN MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 353. SWITZERLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 354. SWITZERLAND MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 355. SWITZERLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 356. SWITZERLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 357. SWITZERLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 358. SWITZERLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 359. SWITZERLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 360. SWITZERLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 361. TURKEY MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 362. TURKEY MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 363. TURKEY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 364. TURKEY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 365. TURKEY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 366. TURKEY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 367. TURKEY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 368. TURKEY MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 369. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 370. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 371. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 372. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 373. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 374. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 375. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 376. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 377. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 378. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 379. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 380. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 381. UNITED KINGDOM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
• TABLE 382. UNITED KINGDOM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
• TABLE 383. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 384. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 385. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 386. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

[187 Pages Report] The Mice Model Market size was estimated at USD 1.49 billion in 2023 and expected to reach USD 1.61 billion in 2024, at a CAGR 8.34% to reach USD 2.61 billion by 2030.

Mice models are laboratory mice (Mus musculus) used by scientists and researchers for biomedical research and studies related to genetic engineering, drug discovery, and therapeutic testing. These models are pivotal in mimicking human disease processes due to the genetic, biological, and behavioral similarities between humans and mice. Mice models enable the scientific community to understand disease mechanisms, assess drug efficacy, and explore potential treatments before they are tested in humans. The increasing demand for personalized medicine, the growing prevalence of various genetic disorders, and a surge in biomedical research involving cancer, cardiovascular diseases, and neurological disorders enhanced the usage of mice models. The rise in regulatory approvals for pharmaceutical drugs also necessitates extensive preclinical studies, further propelling the demand for mice models. Despite the significant growth, the mice model market faces several challenges, such as ethical concerns related to animal testing, the high cost of creating and maintaining genetically engineered mice models, and the complexity of reproducing human diseases in mice. However, the continual development of CRISPR/Cas9 gene-editing technology presents novel avenues for creating more accurate and diverse disease models. Additionally, the increasing investment in biomedical research and development by both public and private sectors worldwide offers a significant boost to the market.

Type: Growing significance of genetically engineered mice for evaluating gene therapy outcomes

Conditioned or surgically modified mice are specifically altered through surgical interventions to create models that represent human conditions not naturally occurring in the mouse genome. These modifications can include the removal of specific organs, the introduction of tumors, or the creation of injury models. This methodology allows for the study of disease mechanisms, the development of surgical techniques, and the evaluation of therapeutics in a controlled environment, closely mimicking the human physiological conditions they aim to replicate. Genetically engineered mice (GEM) are created by manipulating their genetic material. Techniques such as gene knockout, gene knock-in, and transgenesis are employed to introduce, remove, or alter specific genes within the mouse genome. This category of mice models is important for studying gene function, the genetic basis of diseases, and the potential effects of genetic modifications. Hybrid/congenic mice are produced through controlled breeding strategies to combine genetic material from two or more strains to achieve specific genetic backgrounds. Hybrid mice result from mating two different inbred strains, offering heterozygosity and broader genetic diversity, which is beneficial for general health and reproductive performance. Congenic mice, on the other hand, are created by backcrossing hybrids to one of the original inbred strains for multiple generations, allowing for the isolation of specific genetic traits or loci. Inbred mice are derived from at least 20 generations of brother-sister or parent-offspring mating, which results in a genetically uniform strain. These mice are invaluable in research owing to their consistent genetic background, which minimizes variability in experimental studies. Inbred strains are used extensively in the study of genetics, immunology, and disease models, including as platforms for developing genetically engineered models and for pharmacological and toxicological studies. Outbred mice are genetically diverse populations that are kept deliberately heterozygous. This genetic variability mirrors the genetic diversity within human populations, making them particularly useful for toxicology, pharmacology, and safety assessment studies.

Application: Rising adoption of mice models to explore therapeutic efficacy and safety profiles before clinical trials

The applications of mice models in drug discovery and development are essential for the pharmaceutical industry. The physiological and genetic similarities between humans and mice make them invaluable for assessing the efficacy and safety of new pharmaceutical compounds. By utilizing mice models, researchers can elucidate the pharmacokinetic and pharmacodynamic properties of potential therapeutic agents, enabling the identification of promising drug candidates for further development. Moreover, these models help in understanding the mechanism of action, dose-response relationship, and potential toxicity of new drugs before entering human clinical trials, thereby minimizing the risk of failure at later development stages. Mice models are pivotal in the advancement of personalized medicine. Using genetically engineered mice and patient-derived xenografts (PDX), researchers can mimic human genetic conditions and diseases at a high level of accuracy. This enables the study of individual responses to therapeutics based on genetic makeup, leading to more precise and effective treatment strategies. Personalized mice models are instrumental in identifying biomarkers for disease diagnosis, predicting therapeutic outcomes, and evaluating targeted therapies. Besides their significant role in drug development and personalized medicine, mice models are extensively used in various biomedical research applications. These include studying genetics, understanding disease mechanisms, testing immunological responses, and evaluating the impact of environmental factors on health. Mice models have been crucial in advancing our knowledge of complex diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders. Their versatility and adaptability also make them suitable for regenerative medicine studies and aging research, contributing profoundly to expanding biomedical knowledge and exploring new therapeutic avenues.

Regional Insights

The mice model market is growing significantly in the Americas owing to continuous research activities by research organizations and pharmaceutical companies. Moreover, federal government support in terms of grants and investment for drug development and vaccine development has enhanced the scope of the mice model in the region. However, the rising genetic disease and neurological complications in European countries have increased the utilization of mouse models to understand age-related diseases. In addition, emerging clinical research institutes and favorable government initiatives drive market development in the EMEA region. The rising need for personalized medications, surging geriatric disease, increasing cases of immune disease, and growing prevalence of infectious disease boost the adoption of mice models across the Americas and Europe regions. On the other hand, the Asia-Pacific region witnesses significant growth prospects of the mice models market in the forecast period owing to growing research activities and government initiatives for clinical activities. APAC's increasing population and prevalence of chronic diseases underscore the need for extensive research, thereby propelling the adoption of mice models.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Mice Model Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mice Model Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.

Market Segmentation & Coverage

This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Conditioned/Surgically Modified Mice
  • Genetically Engineered Mice
  • Hybrid/Congenic Mice
  • Inbred Mice
  • Outbred Mice

• Technology
  • CRISPR/CAS9
  • Embryonic Stem Cell Injection
  • Microinjection
  • Nuclear Transfer

• Therapeutic Area
  • Cardiovascular Diseases
  • Immunology
  • Metabolic Diseases
  • Neurology
  • Oncology

• Application
  • Drug Discovery & Development
  • Personalized Medicine
  • Research Application

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Mice Model Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mice Model Market?

3. What are the technology trends and regulatory frameworks in the Mice Model Market?

4. What is the market share of the leading vendors in the Mice Model Market?

5. Which modes and strategic moves are suitable for entering the Mice Model Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Escalating use of mice models for drug testing and research of immune disease
    • 5.1.1.2. Rising investments and grants coupled with surging pharmaceutical R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with development of mice models
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging implementation of AI and ML in mice modeling
    • 5.1.3.2. Advent of CRISPR-Cas9 technology in mice modeling
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations and laws considering the ethical use of animals in research
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing significance of genetically engineered mice for evaluating gene therapy outcomes
  • 5.2.2. Application: Rising adoption of mice models to explore therapeutic efficacy and safety profiles before clinical trials
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Mice Model Market, by Type

• 6.1. Introduction
• 6.2. Conditioned/Surgically Modified Mice
• 6.3. Genetically Engineered Mice
• 6.4. Hybrid/Congenic Mice
• 6.5. Inbred Mice
• 6.6. Outbred Mice

7. Mice Model Market, by Technology

• 7.1. Introduction
• 7.2. CRISPR/CAS9
• 7.3. Embryonic Stem Cell Injection
• 7.4. Microinjection
• 7.5. Nuclear Transfer

8. Mice Model Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Immunology
• 8.4. Metabolic Diseases
• 8.5. Neurology
• 8.6. Oncology

9. Mice Model Market, by Application

• 9.1. Introduction
• 9.2. Drug Discovery & Development
• 9.3. Personalized Medicine
• 9.4. Research Application

10. Americas Mice Model Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Mice Model Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Mice Model Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Biocytogen Officially Launches RenMice Series
  • 13.3.2. Introducing NeoMab: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model
  • 13.3.3. A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes
  • 13.3.4. UCLA Researchers Develop First Human Genomic Transgenic Mouse Model Of Huntington's Disease
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio